Improving blood transfusion services

Tancred, Tara; Bates, Imelda

doi:10.1016/j.bpobgyn.2019.05.007

Cited by 5 publications

(5 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Blood shortages impacting patient care were found across the range of low-income to upper-middle income categories. In high-income countries, the HBTS usually obtains their blood supply from accredited external blood collection agencies (nationalised or not-for-profit organisations) using standardised blood donation programmes, and sensitive and specific laboratory tests to prevent transfusion-transmitted diseases 25 26. In LMIC, the HBTS must collect blood when there is no such external blood supplier, or the external supplier cannot provide sufficient blood to meet clinical demand 9 21 26.…”

Section: Discussionmentioning

confidence: 99%

“…In high-income countries, the HBTS usually obtains their blood supply from accredited external blood collection agencies (nationalised or not-for-profit organisations) using standardised blood donation programmes, and sensitive and specific laboratory tests to prevent transfusion-transmitted diseases 25 26. In LMIC, the HBTS must collect blood when there is no such external blood supplier, or the external supplier cannot provide sufficient blood to meet clinical demand 9 21 26. However, the contribution of HBTS blood collection activities in this context is poorly documented in the literature.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Status of hospital-based blood transfusion services in low-income and middle-income countries: a cross-sectional international survey

et al. 2022

View full text Add to dashboard Cite

ObjectivesBlood transfusion is life-saving for patients experiencing acute blood loss and severe anaemia. In low-income and middle-income countries (LMICs), low blood donation rates and unavailability of whole blood and blood components (blood products) impairs timely blood transfusion. To fulfil patient-specific blood orders, a hospital blood transfusion service (HBTS) receives orders from a prescriber for blood transfusion, tests and prepares blood products for the patient. This study sought to describe the current state of LMIC HBTS.DesignA cross-sectional survey explored LMIC HBTS access to blood products, testing methods, policies and structure. Surveys were administered in English, Spanish, French and Russian, followed by a mixed-methods analysis.SettingHBTS within LMICs.ParticipantsFrom among 124 public and private facilities invited to participate, we received 71 (57%) responses. Of these responses, 50 HBTS from 27 LMICs performed on-site blood transfusions.ResultsMost LMIC HBTS perform blood collection to generate blood products for their patients (36/47, 77%); few relied exclusively on an external supply of blood products (11/47, 23%). The primary reason for blood transfusion was adult anaemia for non-malignant conditions (17/112, 15%). Testing methods varied by gross national income per capita. Blood transfusion delays to patients were common (17/30, 57%) attributed to inadequate blood inventories (13/29, 45%). Other barriers included lack of regular clinician education about transfusion (8/29, 28%) and sustainable financial models for the HBTS (4/29, 14%).ConclusionThis survey describes the status of HBTS in diverse LMICs, illustrating that the availability of blood products remains a principal problem, requiring HBTS to generate its own facility’s blood supply. Currently, blood shortages are not reported as a patient-specific adverse event making systematic tracking of delays in transfusion difficult. These findings highlight areas for further exploration related to the lack of available blood inventories for transfusions at HBTS in LMICs.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Status of hospital-based blood transfusion services in low-income and middle-income countries: a cross-sectional international survey

et al. 2022

View full text Add to dashboard Cite

show abstract

“…The usage of a cell saver device is found to be beneficial with regard to the reduction of blood product transfusion in orthopaedic surgeries (spine surgery, hip and knee replacements), trauma surgeries, liver transplantations, oncologic surgeries and cases of postpartum bleeding. 25–29 In the field of cardiovascular surgery, research regarding cell salvage usually involves AAA repair surgeries, off-pump bypass surgeries and other routine cardiac surgeries. 3,7,10,23,30 The current study differs from the others, owing to the fact that it involves investigations concerning the efficacy of the cell saver device and cost-effectiveness in relation to the repair of high-risk aortic pathologies.…”

Section: Discussionmentioning

confidence: 99%

Efficacy and cost-effectiveness of cell saver usage in the repair of thoracic aortic aneurysms and dissections

et al. 2021

View full text Add to dashboard Cite

Introduction: A substantial amount of blood loss occurs during the open repair of aortic aneurysms or dissections. The aim of the present study is to determine the efficacy and cost-effectiveness of cell saver devices in blood conservation during the open repair of thoracic aortic pathologies. Methods: The present study prospectively collected the data pertaining to 25 patients who underwent surgical management of thoracic aortic aneurysms or dissections using a cell saver (Group 1, n = 25). The volume and cost of transfusion and postoperative outcomes were compared with the second group of patients who underwent surgery without the use of cell savers in the previous year (Group 2, n = 25); the data pertaining to the same were retrospectively collected from the hospital records. The patient characteristics and categorical variables were compared using the x2 test and Fisher’s exact test. Transfusion volume and costs were compared using the independent samples t-test and Mann–Whitney U test. Results: The patients in both the groups displayed similar characteristics and risk factors. The total volume of allogenic red blood cell (p < 0.001) and total blood product (p = 0.01) transfusions were significantly lower in Group 1. The cost of red blood cell (p < 0.001) and total transfusions (p = 0.03) were lower in Group 1. The two groups displayed similar in-hospital morbidity and mortality rates. Conclusions: There was a significant association between the use of cell savers and the decreased need for red blood cell and total blood product transfusions. Considering the cost of the cell saver set, transfusion costs in the two groups were comparable.

show abstract

“…En muchos países a nivel mundial, las transfusiones de sangre se usan con más frecuencia como apoyo en trasplantes de corazón y cirugías, para tratar traumas masivos o para el uso terapéutico en oncología. Sin embargo, en países de bajos recursos, dos tercios de las transfusiones de sangre se administran a niños con anemia, seguido por el uso en maternas para el tratamiento de complicaciones, donde la más común es en el posparto hemorrágico 48 . No es sorprendente que el uso de la terapia de transfusión de sangre en diferentes tratamientos esté aumentando, así como las reacciones adversas y junto a ellas la gravedad de las complicaciones 46,49 .…”

Section: Conclusionesunclassified

Efectos adversos en pacientes sometidos a procesos transfusionales.

Luna¹

2021

View full text Add to dashboard Cite

La transfusión sanguínea es un procedimiento comúnmente utilizado; en el cual el paciente recibe sangre o sus componentes con el fin de mejorar la calidad de vida y que esto contribuya con la recuperación total o parcial de la salud de aquellos pacientes que hacen uso de esta práctica. Este procedimiento esta destinado a salvar vidas cuando se pierde en una cirugía, en enfermedades, en trastornos hemorrágicos, lesiones o cuando una enfermedad impide que el cuerpo produzca sangre o algunos componentes. Las transfusiones pueden ser de cada uno de sus componentes (glóbulos rojos, glóbulos blancos, plasma y plaquetas) o pueden ser transfusiones que contiene todos los componentes (no es tan frecuente). En general, las transfusiones de sangre no presentan complicaciones; aunque se han evidenciado riesgos y efectos adversos. Los órganos hepáticos, cardiovascular, hematológico y renal son los que se ven comprometidos a causa de complicaciones transfusionales.

show abstract

Improving blood transfusion services

Cited by 5 publications

References 44 publications

Status of hospital-based blood transfusion services in low-income and middle-income countries: a cross-sectional international survey

Status of hospital-based blood transfusion services in low-income and middle-income countries: a cross-sectional international survey

Efficacy and cost-effectiveness of cell saver usage in the repair of thoracic aortic aneurysms and dissections

Efectos adversos en pacientes sometidos a procesos transfusionales.

Contact Info

Product

Resources

About